ferrets report on bourse

  1. blt
    164 Posts.
    Sydney - Tuesday - November 25: (RWE)

    Some share price moves to keep an eye on in the market:

    HARVEY NORMAN (HVN) up 10c to $3.05: Sales rose 20.6 per cent to
    $1.178 billion in the four months to October 31. Like-for-like sales were
    up 15.2 per cent.

    BLACKMORES (BKL) down 10c to $7.65: A newspaper report today said
    that the business and assets of the troubled rival Pan Pharmaceuticals
    had been purchased by contract pill maker Tabco. Tabco had been the
    largest contract manufacturer for Blackmores until last year, when
    Blackmores switched to other suppliers and Tabco's owners subsequently
    sold down their Blackmores shares.

    Nanotechnology Research and Development Act has been passed in the US
    House of Representatives. The Act authorises $US3.7 billion over the next
    four years for the creation of the National Nanotechnology Co-ordination
    Office and the funding of federal government nanotechnology programs.

    BRESAGEN (BGN) up 2.5c to 27c: Will assign a number of its
    licences relating to catheters for cell delivery to US-based devices
    company NexGen Technologies. NexGen will provide BresaGen with a
    non-exclusive licence to use the FDA-approved neurological cell therapy
    catheter with its own products, such as a treatment for Parkinson's
    Disease. BresaGen will also receive about $380,000 as an upfront payment
    for the assignment and will be granted shares representing 4 per cent of

    FKP (FKP) up 11c to $2.36: Won the tender for Stage 2 of
    Brisbane's Newstead Riverpark Gateway, worth $42 million. The company
    plans to develop a commercial precinct and a separate civic precinct on
    the site.

    MOSAIC OIL (MOS) up 1.5c to 19c: Announced its "revolutionary"
    coiled tubing horizontal drilling with nitrified liquids had struck gas
    in its first attempt on Tinker 3H. It penetrated an upper sand overnight
    and was flowing at an estimated 4 million cubic feet of gas a day,
    directors said.

    PSIVIDA (PSD) up 2c to 53c: Signed a licensing agreement with
    German research agency Forschungszentrum Julich to acquire rights in the
    use of porous silicon mirror technology. PSivida intends to commercialise
    the mirror using its BioSilicon diagnostic technology, for the
    development of early stage detection and monitoring devices for diseases
    such as cancer.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.